ETNB
89bio Inc · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website 89bio.com
- Employees(FY) 45
- ISIN US2825591033
Performance
-5.27%
1W
-7.9%
1M
-11.4%
3M
+15.68%
6M
-22.74%
YTD
-51.08%
1Y
Profile
89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. The company's lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis; and for the treatment of severe hypertriglyceridemia. 89bio, Inc. was incorporated in 2018 and is headquartered in San Francisco, California.
Investment Analysis Report: ETNB
Overview
ETNB is a pharmaceutical company operating in the Health Technology sector, with a market capitalization of $884,135,351. The company's industry focus is on Pharmaceuticals: Major. In this report, we will conduct a comprehensive analysis of ETNB's financial statements over the past three years, including...
Technical Analysis of ETNB 2024-05-10
Overview:
In analyzing the technical indicators for ETNB over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key aspects, we aim to offer valuable insights and predictions for informed decisio...
Recent News & Updates
- 2024-05-14 08:00
- 2024-05-13 20:00
- 2024-05-10 16:05
- 2024-05-10 14:16
- 2024-05-10 04:05
- 2024-05-09 16:05
- 2024-05-09 10:54
ETNB Stock Earnings: 89bio Misses EPS for Q1 2024(Investorplace)
- 2024-05-09 04:05
- 2024-05-08 23:56
- 2024-05-08 16:05
- 2024-05-08 04:05
- 2024-05-06 00:00
- 2024-05-02 16:05
- 2024-05-02 04:05
- 2024-04-17 16:05
- 2024-04-17 04:05
- 2024-04-05 16:05
- 2024-04-05 04:05
- 2024-04-03 19:01
89bio Inc CEO Rohan Palekar Sells 52,718 Shares(GuruFocus.com)
- 2024-03-27 08:00
- 2024-03-26 20:00
- 2024-03-18 07:00
Ozempic Can’t Do It All—A Potential New Blockbuster Is a Reminder of That(The Wall Street Journal)
- 2024-03-13 07:07
13 Best Biotech Stocks To Buy Under $20(Insider Monkey)
- 2024-03-12 19:07
13 Best Biotech Stocks To Buy Under $20(Insidermonkey)
- 2024-03-12 08:00
- 2024-03-11 20:00
- 2024-03-08 16:05
- 2024-03-08 03:05
- 2024-03-07 00:34
- 2024-03-05 16:05
Page 1 of 6
previousnext